Cargando…

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

BACKGROUND: Apo2L/TRAIL has considerable promise for cancer therapy based on the fact that this member of the tumor necrosis factor family induces apoptosis in the majority of malignant cells, while normal cells are more resistant. Furthermore, in many cells, when Apo2L/TRAIL is combined with chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hylander, Bonnie L, Pitoniak, Rose, Penetrante, Remedios B, Gibbs, John F, Oktay, Dilek, Cheng, Jinrong, Repasky, Elizabeth A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156958/ https://www.ncbi.nlm.nih.gov/pubmed/15943879 http://dx.doi.org/10.1186/1479-5876-3-22

Ejemplares similares

Origin of the vasculature supporting growth of primary patient tumor xenografts
por: Hylander, Bonnie L, et al.
Publicado: (2013)

Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5
por: Eng, Jason W.-L., et al.
Publicado: (2016)

Uncovering a connection between physiological stress and therapeutic resistance in tumor cells
por: Eng, Jason W, et al.
Publicado: (2013)

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
por: El-Zawahry, Ahmed, et al.
Publicado: (2005)

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
por: Oflazoglu, Ezogelin, et al.
Publicado: (2007)

Using Mice to Model Human Disease: Understanding the Roles of Baseline Housing-Induced and Experimentally Imposed Stresses in Animal Welfare and Experimental Reproducibility
por: Hylander, Bonnie L., et al.
Publicado: (2022)

Heat shock proteins and cancer therapy: The trail grows hotter!
por: Repasky, Elizabeth A., et al.
Publicado: (2011)

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection
por: Fu, Wenkun, et al.
Publicado: (2021)

Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma
por: Zaccagnino, Angela, et al.
Publicado: (2016)

MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma
por: Rossignoli, Filippo, et al.
Publicado: (2019)

The impact of β-adrenergic signaling on radioresistance and anti-tumor immunity
por: Bucsek, Mark, et al.
Publicado: (2015)

Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
por: Qiao, Guanxi, et al.
Publicado: (2018)

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis
por: Abdulghani, Junaid, et al.
Publicado: (2013)

Genetics of SCID
por: Cossu, Fausto
Publicado: (2010)

Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019)

Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model
por: Thies, A, et al.
Publicado: (2008)

Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis
por: Unno, Kenji, et al.
Publicado: (2014)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016)

Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment
por: Rimmer, Ella, et al.
Publicado: (2022)

TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice
por: Cartland, Siân P., et al.
Publicado: (2014)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
por: Inoue, Takeshi, et al.
Publicado: (2013)

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
por: Shankar, Sharmila, et al.
Publicado: (2008)

Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice
por: Islam, Mohammed M., et al.
Publicado: (2015)

E- and P-Selectins Are Essential for Repopulation of Chronic Myelogenous and Chronic Eosinophilic Leukemias in a Scid Mouse Xenograft Model
por: Wicklein, Daniel, et al.
Publicado: (2013)

Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts
por: Andersen, Lise Mari K., et al.
Publicado: (2017)

Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
por: Miller, Aubrey L., et al.
Publicado: (2020)

Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, (111)In or β-particle emitting, (177)Lu
por: Aghevlian, Sadaf, et al.
Publicado: (2020)

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
por: Arizono, Y, et al.
Publicado: (2003)

Optimisation and molecular signalling of apoptosis in sequential cryotherapy and chemotherapy combination in human A549 lung cancer xenografts in SCID mice
por: Forest, V, et al.
Publicado: (2009)

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
por: Bhadri, Vivek A, et al.
Publicado: (2011)

D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
por: Righi, Marco, et al.
Publicado: (2013)

Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice
por: Salamon, Johannes, et al.
Publicado: (2014)

Defining Immunological Impact and Therapeutic Benefit of Mild Heating in a Murine Model of Arthritis
por: Lee, Chen-Ting, et al.
Publicado: (2015)

The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation.
por: Sharma, R., et al.
Publicado: (1997)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines
por: Wennerström, Anna B., et al.
Publicado: (2014)

Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
por: Usai, Alice, et al.
Publicado: (2021)

Reference genomes for BALB/c Nude and NOD/SCID mouse models
por: Schmid-Siegert, Emanuel, et al.
Publicado: (2023)

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
por: Zhang, H, et al.
Publicado: (2014)

Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)
por: Singh, Kamini, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b40mph4k788rvor2tdks5nsuo4